Press Releases


Sign up to get full access to all our our latest Press Releases. Sign Up
March 27, 2017

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

Aphria through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).

March 21, 2017

Aphria Continues Success Story with TSX Listing

Aphria today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.

March 8, 2017

Aphria Affirms its Commitment to Producing Safe Medical Cannabis

In light of recent media coverage, Aphria Inc. issued the following statement with respect to its ongoing commitment to providing pharmaceutical-grade cannabis that is free of chemical pesticides.

February 23, 2017

Aphria Announces Additional Investment in Kalytera

Aphria is pleased to announce it has closed its short form prospectus offering, on a bought deal basis.

February 6, 2017

Aphria announces $50 million bought deal

Aphria has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters.

February 6, 2017

Aphria receives conditional approval to graduate to the TSX

Aphria is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange and…

January 16, 2017

Aphria’s Vision to be Reality – Part IV expansion

Aphria is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion (“Part IV”). The project will…

January 11, 2017

Aphria reports 19% growth in quarterly revenue

Quarterly EBITDA exceeds $1 million - 2nd consecutive quarter of positive cash flow from operating activities. Aphria Inc. today reported its second quarter results, for…

December 29, 2016

Aphria comments on today’s Globe and Mail story on pesticide use

Aphria welcomes independent product testing as a measure to protect patient safety. Aphria Inc. has always prided itself on being an industry leader when it…

December 21, 2016

Aphria announces final approval of Copperstate Transaction

Aphria Inc. is pleased to announce that the TSX – Venture Exchange provided Final Approval of the Company’s previously announced investments in Copperstate Farms, LLC…

December 15, 2016

Aphria supports majority of Task Force recommendations

"The Task Force's mandate to provide recommendations that balance both the health and well-being of Canadians and the need to shut down the black market…

December 14, 2016

Aphria continues expansion strategy

Aphria acquires additional 200 acres in Leamington, Ontario. Aphria Inc. announced today that the Company entered into a purchase and sale agreement to acquire 200…